1 Healthcare Giant That Isn't Jumping on the GLP-1 Bandwagon, and Why That Could Be a Great Move

1 Healthcare Giant That Isn't Jumping on the GLP-1 Bandwagon, and Why That Could Be a Great Move

Submitted by admin on October 17, 2024 - 9:24am
Source: 
Motley Fool
News Tags: 
Novartis
GLP-1 agonists
obesity
weight loss
Headline: 
1 Healthcare Giant That Isn't Jumping on the GLP-1 Bandwagon, and Why That Could Be a Great Move
snippet: 
  • The anti-obesity market has many healthcare companies rushing to develop GLP-1 treatments.
  • The competition is likely to be intense, however, and bringing a drug to market could be incredibly costly.
  • Novartis has decided to focus on other growth opportunities instead, where it sees better odds of success.

Do Not Allow Advertisers to Use My Personal information